Cargando…
Adenoviral vector‐based platforms for developing effective vaccines to combat respiratory viral infections
Since the development of the first vaccine against smallpox over two centuries ago, vaccination strategies have been at the forefront of significantly impacting the incidences of infectious diseases globally. However, the increase in the human population, deforestation and climate change, and the ri...
Autores principales: | Elkashif, Ahmed, Alhashimi, Marwa, Sayedahmed, Ekramy E, Sambhara, Suryaprakash, Mittal, Suresh K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510854/ https://www.ncbi.nlm.nih.gov/pubmed/34667600 http://dx.doi.org/10.1002/cti2.1345 |
Ejemplares similares
-
Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines
por: Sayedahmed, Ekramy E., et al.
Publicado: (2020) -
Nonhuman Adenoviral Vector-Based Platforms and Their Utility in Designing Next Generation of Vaccines for Infectious Diseases
por: Alhashimi, Marwa, et al.
Publicado: (2021) -
A Bovine Adenoviral Vector-Based H5N1 Influenza -Vaccine Provides Enhanced Immunogenicity and Protection at a Significantly Low Dose
por: Sayedahmed, Ekramy E., et al.
Publicado: (2018) -
Significance of Preexisting Vector Immunity and Activation of Innate Responses for Adenoviral Vector-Based Therapy
por: Wang, Wen-Chien, et al.
Publicado: (2022) -
Progress towards the Development of a Universal Influenza Vaccine
por: Wang, Wen-Chien, et al.
Publicado: (2022)